184 related articles for article (PubMed ID: 10492380)
1. 99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging.
Guo W; Hinkle GH; Lee RJ
J Nucl Med; 1999 Sep; 40(9):1563-9. PubMed ID: 10492380
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical.
Trump DP; Mathias CJ; Yang Z; Low PS; Marmion M; Green MA
Nucl Med Biol; 2002 Jul; 29(5):569-73. PubMed ID: 12088727
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-Tetraethylenepentamine-Folate--a new 99mTc-based folate derivative for the detection of folate receptor positive tumors: synthesis and biological evaluation.
Panwar P; Shrivastava V; Tandon V; Mishra P; Chuttani K; Sharma RK; Chandra R; Mishra AK
Cancer Biol Ther; 2004 Oct; 3(10):995-1001. PubMed ID: 15467429
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis and animal imaging of 99mTc-hydrazinonicotinamide-folate as a new folate receptor-targeted tumor imaging agent].
Liu LQ; Wang SZ; Li F; Teng B; Wang KZ; Qiu FC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):786-9. PubMed ID: 17260467
[TBL] [Abstract][Full Text] [Related]
5. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical.
Mathias CJ; Wang S; Waters DJ; Turek JJ; Low PS; Green MA
J Nucl Med; 1998 Sep; 39(9):1579-85. PubMed ID: 9744347
[TBL] [Abstract][Full Text] [Related]
6. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
Mathias CJ; Wang S; Lee RJ; Waters DJ; Low PS; Green MA
J Nucl Med; 1996 Jun; 37(6):1003-8. PubMed ID: 8683292
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
Mishra G; Hazari PP; Kumar N; Mishra AK
J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
[TBL] [Abstract][Full Text] [Related]
8. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
Müller C; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Apr; 49(4):623-9. PubMed ID: 18344429
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.
Reddy JA; Xu LC; Parker N; Vetzel M; Leamon CP
J Nucl Med; 2004 May; 45(5):857-66. PubMed ID: 15136637
[TBL] [Abstract][Full Text] [Related]
10. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
Müller C; Forrer F; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.
Decristoforo C; Melendez-Alafort L; Sosabowski JK; Mather SJ
J Nucl Med; 2000 Jun; 41(6):1114-9. PubMed ID: 10855644
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Evaluation of (99m)Tc-Labeled Dimeric Folic Acid for FR-Targeting.
Guo Z; Gao M; Song M; Shi C; Zhang P; Xu D; You L; Zhuang R; Su X; Liu T; Du J; Zhang X
Molecules; 2016 Jun; 21(6):. PubMed ID: 27338334
[TBL] [Abstract][Full Text] [Related]
13. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
Choi H; Choi SR; Zhou R; Kung HF; Chen IW
Acad Radiol; 2004 Sep; 11(9):996-1004. PubMed ID: 15350580
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro/in vivo evaluation of 99mTc-labeled folate conjugates for folate receptor imaging.
Lu J; Pang Y; Xie F; Guo H; Li Y; Yang Z; Wang X
Nucl Med Biol; 2011 May; 38(4):557-65. PubMed ID: 21531293
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy.
De K; Bhowmik A; Behera A; Banerjee I; Ghosh MK; Misra M
J Pept Sci; 2012 Dec; 18(12):720-30. PubMed ID: 23109400
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging.
Wang S; Lee RJ; Mathias CJ; Green MA; Low PS
Bioconjug Chem; 1996; 7(1):56-62. PubMed ID: 8741991
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical.
Mathias CJ; Hubers D; Low PS; Green MA
Bioconjug Chem; 2000; 11(2):253-7. PubMed ID: 10725102
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-ethylenedicysteine-folate: a new tumor imaging agent. Synthesis, labeling and evaluation in animals.
Ilgan S; Yang DJ; Higuchi T; Zareneyrizi F; Bayhan H; Yu D; Kim EE; Podoloff DA
Cancer Biother Radiopharm; 1998 Dec; 13(6):427-35. PubMed ID: 10851435
[TBL] [Abstract][Full Text] [Related]
20. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
